PLSE Stock Analysis: Buy, Sell, or Hold?
PLSE - Pulse Biosciences, Inc Common Stock (DE)
$23.03
1.44 (6.67%)
▲
5d:
+4.59%
30d:
+28.3%
90d:
+68.1%
HOLD
MODERATE Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 14, 2026
Smart Money Accumulation
PLSE is down 6.9% this week, but smart money is accumulating calls. Top strike: $25 2026-05-15 with 1 OI. Call ratio: 100% View Scanner →
Strength: 8.5/10
Get Alerted When PLSE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PLSE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: PLSE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: PLSE is currently trading at $23.03, which is considered extended relative to its 30-day fair value range of $18.81 to $21.93.
Technical Outlook: Technically, PLSE is in a strong uptrend. The price is approaching resistance at $23.18. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 6.7% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PLSE is in a strong uptrend. The price is approaching resistance at $23.18. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 6.7% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$18.81 -
$21.93
Company Quality Score
59/100
(HOLD)
Options IV Signal
33th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
50.8%
All Signals
- BEARISH: Price extended above range (+5.0% above fair value)
- NEUTRAL: Options fairly priced (IV 33th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.7%)
- NEUTRAL: Near Wall St target ($22.00)
Fair Price Analysis
30-Day Fair Range
$18.81 -
$21.93
Current vs Fair Value
EXTENDED
Expected Move (7 Days)
±$3.67
(16.0%)
Support & Resistance Levels
Support Level
$19.52
Resistance Level
$23.18
Current Trend
Strong Uptrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-13.87
Wall Street Target
$22.00
(-4.5%)
Share & Embed Analysis
Last updated: April 02, 2026 3:56 AM ET
Data refreshes hourly during market hours. Next update: 4:56 AM
Data refreshes hourly during market hours. Next update: 4:56 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PLSE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Kevin Patrick Danahy
SELL
5000 shares
2026-02-18
Kevin Patrick Danahy
SELL
20000 shares
2026-02-17
Kevin Patrick Danahy
SELL
20000 shares
2026-02-13
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$607 | 61 BUY |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$94 | 59 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$186 | 58 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$297 | 61 BUY |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$318 | 62 BUY |
